Gramatica, A., Miller, I. G., Ward, A. R., Khan, F., Kemmer, T. J., Weiler, J., Huynh, T. T., Zumbo, P., Kurland, A. P., Leyre, L., Ren, Y., Klevorn, T., Copertino, D. C., Chukwukere, U., Levinger, C., Dilling, T. R., Linden, N., Board, N. L.
, Falling Iversen, E. ... Jones, R. B. (2025).
EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes.
Cell Reports,
44(5), Artikel 115652.
https://doi.org/10.1016/j.celrep.2025.115652Borup, A., Sharifpour, M. F.
, Rossen, L. S., Whitehead, B., Boysen, A. T., Olesen, R., Bohn, A. B., Ridolfi, A., Brucale, M., Valle, F., Paolini, L., Radeghieri, A., Bergese, P., Miles, K., Veitch, M., Thomas, T., Ruscher, R., Wangchuk, P., Giacomin, P.
... Nejsum, P. (2025).
Helminth extracellular vesicles co-opt host monocytes to drive T cell anergy.
Journal of Extracellular Vesicles,
14(1), Artikel e70027.
https://doi.org/10.1002/jev2.70027
Cham, L. B., Hamdan, T. A., Bhat, H., Sirajo, B., Ali, M., Tabbara, K. S., Farid, E., Barbouche, M. R. & Adomati, T. (2025).
Immunotherapeutic Blockade of CD47 Increases Virus Neutralization Antibodies.
Vaccines,
13(6), Artikel 602.
https://doi.org/10.3390/vaccines13060602
Råket, H. K., Jensen, C. B., Wang, J. N., Pressler, T.
, Olesen, H. V., Skov, M.
, Jensen-Fangel, S., Petersen, J., Jimenez-Solem, E. & for the TransformCF study group (2025).
Impact of elexacaftor/tezacaftor/ivacaftor on utilization of routine therapies in cystic fibrosis: Danish nationwide register study.
Journal of Cystic Fibrosis,
24(1), 105-111.
https://doi.org/10.1016/j.jcf.2024.11.004